Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Upstream-therapy by Telmisartan and Amlodipine Combination for Improvement of Left Atrial Mechanical Function After Pulmonary Vein Antrum Isolation

NCT02734355 is registered in ClinicalTrials.gov with Research Institute for Complex Problems of Cardiovascular Diseases, Russia as lead sponsor.

NCT NCT02734355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02734355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Upstream-therapy by Telmisartan and Amlodipine Combination for Improvement of Left Atrial Mechanical Function After Pulmonary Vein Antrum Isolation
Lead sponsor
Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2015
Completion date
February 29, 2016
Enrollment
64 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation